152 related articles for article (PubMed ID: 24879590)
1. LKB1 loss at transcriptional level promotes tumor malignancy and poor patient outcomes in colorectal cancer.
He TY; Tsai LH; Huang CC; Chou MC; Lee H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S703-10. PubMed ID: 24879590
[TBL] [Abstract][Full Text] [Related]
2. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
3. The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss.
Tsai LH; Wu JY; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2015 Mar; 34(13):1641-9. PubMed ID: 24793789
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer.
Lin PL; Wu DW; Huang CC; He TY; Chou MC; Sheu GT; Lee H
Carcinogenesis; 2014 Oct; 35(10):2175-82. PubMed ID: 24832083
[TBL] [Abstract][Full Text] [Related]
5. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein represses LKB1 expression to promote tumor progression and poor postoperative outcome in hepatocellular carcinoma.
Wu CC; Wu DW; Lin YY; Lin PL; Lee H
Surgery; 2018 May; 163(5):1040-1046. PubMed ID: 29475611
[TBL] [Abstract][Full Text] [Related]
7. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
Chen PM; Wu TC; Cheng YW; Chen CY; Lee H
Oncotarget; 2015 Jun; 6(16):14274-89. PubMed ID: 25881545
[TBL] [Abstract][Full Text] [Related]
8. Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.
Chen PM; Wu TC; Wang YC; Cheng YW; Sheu GT; Chen CY; Lee H
Carcinogenesis; 2013 Nov; 34(11):2655-63. PubMed ID: 23784082
[TBL] [Abstract][Full Text] [Related]
9. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
[TBL] [Abstract][Full Text] [Related]
10. Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.
Co NN; Iglesias D; Celestino J; Kwan SY; Mok SC; Schmandt R; Lu KH
Cancer; 2014 Nov; 120(22):3457-68. PubMed ID: 25042259
[TBL] [Abstract][Full Text] [Related]
11. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer.
Wu DW; Tsai LH; Chen PM; Lee MC; Wang L; Chen CY; Cheng YW; Lee H
Am J Pathol; 2012 Nov; 181(5):1796-806. PubMed ID: 22982189
[TBL] [Abstract][Full Text] [Related]
12. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
Zeng PY; Berger SL
Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.
Lin BR; Huang MT; Chen ST; Jeng YM; Li YJ; Liang JT; Lee PH; Chang KJ; Chang CC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S385-94. PubMed ID: 21681381
[TBL] [Abstract][Full Text] [Related]
15. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
16. p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin.
Sui X; Zhu J; Tang H; Wang C; Zhou J; Han W; Wang X; Fang Y; Xu Y; Li D; Chen R; Ma J; Jing Z; Gu X; Pan H; He C
Oncotarget; 2015 Sep; 6(26):22869-79. PubMed ID: 26362504
[TBL] [Abstract][Full Text] [Related]
17. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
18. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
19. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
[TBL] [Abstract][Full Text] [Related]
20. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
Zajkowicz A; Rusin M
Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
